VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EGEverest Group, Ltd.
$420.04$15.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEGFinancials

Everest Group, Ltd. (EG) Income Statement

30Y historyFree accessUpdated daily

Revenue has fallen from $4.6B to $3.7B over the ten-quarter window while combined ratios swung between 79.8% and 116.1%, indicating that profitability depends heavily on large-loss timing.

Income StatementBalance SheetCash FlowRatios

EG Income Statement

Annual statement

EG Income Statement

Everest Group, Ltd. (EG) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue16.16B17.32B17.08B14.46B11.98B11.33B9.6B8.23B7.36B6.62B5.79B5.68B5.68B5.64B4.92B4.69B4.71B4.5B3.53B4.78B4.52B4.56B5.02B4.11B2.56B1.8B1.48B2.61B1.32B1.3B1.17B
Revenue Growth %-7.69%1.42%18.06%20.68%5.8%18.02%16.61%11.81%11.16%14.29%2.07%-0.04%0.68%14.59%4.88%-0.25%4.61%27.53%-26.23%5.86%-0.99%-9.07%22.16%60.58%41.97%21.74%-43.4%98.78%1.23%11.11%-
Medical Costs & Claims10.6B13.76B14.61B11.38B10.63B9.6B8.42B6.63B7.17B5.83B4.33B4.25B4B3.78B3.7B4.68B3.88B2.37B2.44B2.7B2.57B3.85B3.41B2.69B2.25B1.27B936.25M819.83M827.97M326.5M56.5M
Medical Cost Ratio %65.59%79.48%85.53%78.67%88.68%84.75%87.77%80.51%97.4%87.98%74.7%74.84%70.38%66.97%75.12%99.63%82.4%52.77%69.14%56.48%56.95%84.47%67.88%65.61%88.01%70.41%63.27%31.36%62.95%25.13%4.83%
Gross Profit5.56B3.55B2.47B3.08B1.36B1.73B1.17B1.6B191.06M795.75M1.47B1.43B1.68B1.86B1.22B17.24M828.24M2.12B1.09B2.08B1.94B708.34M1.61B1.41B306.62M533.14M543.58M1.79B487.24M972.7M1.11B
Gross Margin %34.41%20.52%14.47%21.33%11.32%15.25%12.23%19.49%2.6%12.02%25.3%25.16%29.62%33.03%24.88%0.37%17.6%47.23%30.86%43.52%43.05%15.53%32.12%34.39%11.99%29.59%36.73%68.64%37.05%74.87%95.17%
Gross Profit Growth %-43.82%-19.9%127.34%-21.47%47.19%-26.83%739.8%-75.99%-45.72%2.63%-15.07%-9.72%52.1%7006.31%-97.92%-61.02%95.16%-47.7%7.01%174.57%-56.04%14.09%360.65%-42.49%-1.92%-69.71%268.31%-49.91%-12.59%-
Operating Expenses2.96B1.6B976M931M769M184M588M505.56M433.24M376.34M366.18M316.51M295.06M308.06M285.32M251.18M237M1.19B1.17B1.05B953.15M989.26M1.05B921.22M44.57M442.8M311.83M1.6B274.56M00
OpEx / Revenue %18.29%9.24%5.72%6.44%6.42%1.62%6.13%6.14%5.89%5.68%6.32%5.58%5.2%5.46%5.8%5.35%5.04%26.35%33.23%22.03%21.1%21.68%20.96%22.43%1.74%24.58%21.07%61.12%20.88%0%0%
Depreciation & Amortization0000000000000000000-8.43M21.95M27.46M24.92M10.64M-7.34M152K112K0000
Combined Ratio %83.88%88.72%91.25%85.11%95.09%86.37%93.89%86.65%103.29%93.67%81.02%80.41%75.58%72.43%80.91%104.98%87.44%79.12%102.37%78.5%78.05%106.16%88.85%88.04%89.75%94.99%84.34%92.48%83.83%25.13%4.83%
Operating Income2.61B1.95B1.5B2.15B588M1.54B586M1.1B-242.18M419.41M1.1B1.11B1.39B1.55B939.53M-233.95M591.24M939.32M-83.61M1.03B991.75M-280.92M559.7M491.21M262.04M90.34M231.74M196.58M212.68M972.7M1.11B
Operating Margin %16.12%11.28%8.75%14.89%4.91%13.63%6.11%13.35%-3.29%6.33%18.98%19.59%24.42%27.57%19.09%-4.98%12.56%20.88%-2.37%21.5%21.95%-6.16%11.15%11.96%10.25%5.01%15.66%7.52%16.17%74.87%95.17%
Operating Income Growth %-30.7%-30.59%266.33%-61.92%163.48%-46.68%553.79%-157.74%-61.87%-1.08%-19.82%-10.81%65.51%501.6%-139.57%-37.06%1223.5%-108.13%3.65%453.04%-150.19%13.94%87.45%190.05%-61.02%17.89%-7.57%-78.14%-12.59%-
EBITDA2.64B2.07B1.64B2.29B689M1.62B621M1.13B-211.15M451.01M1.14B1.15B1.43B1.6B993.21M-181.63M647.07M1.01B-4.44M1.02B1.01B-253.46M584.62M501.85M254.71M90.5M231.85M198.07M212.68M972.7M1.11B
EBITDA Margin %16.34%11.94%9.62%15.82%5.75%14.27%6.47%13.74%-2.87%6.81%19.61%20.22%25.1%28.38%20.18%-3.87%13.75%22.48%-0.13%21.32%22.44%-5.56%11.65%12.22%9.96%5.02%15.67%7.58%16.17%74.87%95.17%
Interest Expense133M139M149M134M101M70M36M31.69M31.03M31.6M36.23M36.19M38.53M46.12M53.68M52.32M55.83M72.08M79.17M91.56M68.6M72.96M75.54M57.29M44.57M46M39.39M1.49M000
Non-Operating Income-36M-114M-147M-134M-101M-72M-35M-31.69M-31.03M-31.6M-36.23M-36.19M-38.53M-46.12M-53.68M-52.32M-55.83M-72.08M-79.17M-91.56M-68.6M-72.96M-75.54M-57.29M-44.57M-46M-39.39M-1.49M000
Pretax Income2.28B1.93B1.49B2.15B588M1.55B585M1.1B-242.18M419.41M1.1B1.11B1.39B1.55B939.53M-233.95M591.24M939.32M-83.61M1.03B991.75M-280.92M559.7M491.21M262.04M90.34M231.74M196.58M212.68M207.3M143.8M
Pretax Margin %14.13%11.14%8.74%14.89%4.91%13.65%6.1%13.35%-3.29%6.33%18.98%19.59%24.42%27.57%19.09%-4.98%12.56%20.88%-2.37%21.5%21.95%-6.16%11.15%11.96%10.25%5.01%15.66%7.52%16.17%15.96%12.3%
Income Tax393M339M120M-363M-9M167M71M89.53M-331.22M-63.34M103.5M134.02M187.65M289.71M110.57M-153.46M-19.52M132.33M-64.85M188.68M150.92M-62.25M64.9M65.19M30.74M-8.68M45.36M38.52M47.48M52.3M31.8M
Effective Tax Rate %17.21%17.57%8.04%-16.85%-1.53%10.8%12.14%8.15%136.77%-15.1%9.41%12.05%13.53%18.63%11.77%65.6%-3.3%14.09%77.56%18.35%15.22%22.16%11.6%13.27%11.73%-9.6%19.57%19.6%22.32%25.23%22.11%
Net Income1.89B1.59B1.37B2.52B597M1.38B514M1.01B89.04M482.75M996.34M977.87M1.2B1.26B828.95M-80.49M610.75M806.99M-18.76M839.27M840.83M-218.67M494.9M426.03M231.3M99.02M186.38M158.06M165.2M155M112M
Net Margin %11.7%9.19%8.04%17.4%4.98%12.17%5.36%12.26%1.21%7.29%17.2%17.23%21.12%22.33%16.84%-1.71%12.98%17.94%-0.53%17.55%18.61%-4.79%9.86%10.37%9.04%5.5%12.59%6.05%12.56%11.93%9.58%
Net Income Growth %242.57%15.88%-45.45%321.61%-56.71%168.29%-49.08%1033.7%-81.56%-51.55%1.89%-18.45%-4.78%51.92%1129.94%-113.18%-24.32%4402.11%-102.24%-0.18%484.52%-144.18%16.17%84.19%133.6%-46.87%17.92%-4.32%6.58%38.39%-
EPS (Diluted)50.2937.8631.7860.2415.1934.6212.7824.702.5311.3623.6822.1025.9125.4415.79-1.4910.7013.22-0.3013.1912.87-3.798.717.744.522.104.023.258.147.976.07
EPS Growth %253.5%19.13%-47.24%296.58%-56.12%170.89%-48.26%876.28%-77.73%-52.03%7.15%-14.7%1.85%61.11%1159.73%-113.93%-19.06%4506.67%-102.27%2.49%439.58%-143.51%12.53%71.24%115.24%-47.76%23.69%-60.07%2.13%31.3%-
EPS (Basic)-37.8631.7860.1915.1934.6612.8124.772.5411.4323.8522.2926.1625.6715.85-1.4910.7313.26-0.3013.3012.99-3.798.857.894.602.144.063.268.198.016.10
Diluted Shares Outstanding37.6M41.41M42.7M41.3M39M39.3M39.73M40.42M40.93M41.28M42.08M44.25M46.28M49.5M52.5M54.02M57.08M61.04M61.67M63.63M65.32M57.65M56.82M55.01M51.14M47.11M46.36M48.69M50.66M50.77M50.68M

Key Metrics

Growth RegimeContracting
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Loss volatility and reserve uncertainty

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Top Line Shrinking Across Recent Quarters

Based on EG's reported figures, quarterly revenue fell from $4.6B in Q4 2024 to $3.7B in Q3 2026, with year-over-year declines of 12.7% and 10.1% in the two most recent quarters, pointing to a softening premium base.

The revenue decline suggests either rate softening in reinsurance pricing or a deliberate reduction in written exposure as the market turns less favorable. Without disclosed premium written and retention data in the supplied figures, volume and price effects cannot be separated, so investors should monitor whether shrinkage reflects underwriting discipline or competitive loss of business. A contracting top line also raises the question of whether margin preservation is coming at the expense of future earned premium.

Underwriting Results Swing With Loss Activity

Reported loss ratios ranged from 54.5% in Q1 2026 to 110.0% in Q4 2024, with combined ratios moving between 79.8% and 116.1%, indicating that underwriting profitability depends heavily on catastrophe and large-loss timing.

The combined ratio sat above 100% only in Q4 2024, while most other quarters landed in the 82% to 94% range, which suggests underwriting profit is the norm but is punctuated by severe loss quarters. The Q2 2026 loss ratio of 82.8% against a Q1 figure of 54.5% reinforces that earnings volatility is driven by event timing rather than a steady trend. Analysts should treat any single quarter's combined ratio with caution and focus on multi-year averages.

Reserve Development Not Visible in Supplied Data

The supplied income statement data does not include prior-year reserve development figures, so whether reported underwriting results benefit from reserve releases cannot be determined from these reported figures.

Reserve development is the most important quality-of-earnings check for a reinsurer, and its absence from this dataset means any conclusion about earnings inflation would be speculative. Quarters with favorable combined ratios, such as Q2 2024 at 79.8%, may or may not reflect releases, and that question warrants further investigation through the full filing. Investors should review prior-year development disclosures before relying on the margin trend.

Investment Income Contribution Unavailable

Investment income and investment yield are not populated in the supplied quarterly data, so the contribution of investment returns to net income cannot be quantified from reported figures.

Because net income is reported but investment income is blank, the split between underwriting and investment earnings is unknown, which limits assessment of how much earnings depend on the portfolio. Net income swings from a $593M loss to $724M profit suggest that underwriting results drive most of the variability, but this inference is not confirmed by the provided numbers. Investors should obtain the investment income line before drawing conclusions about rate sensitivity.

Q4 2024 Loss Quarter Marks Inflection

According to reported financials, Q4 2024 produced a loss ratio of 110.0% and a net loss of $593M on revenue of $4.6B, the sharpest deterioration in the ten-quarter window and a clear inflection point.

The swing from a $724M profit in Q2 2024 to a $593M loss in Q4 2024 is the defining event in this dataset, and it appears driven by a loss spike rather than a revenue collapse since revenue actually rose 27.2% that quarter. Earnings recovered to $446M by Q4 2025, but the recovery has not yet matched the pre-loss run rate. Whether this reflects a single severe event or a broader reserve or pricing issue warrants further investigation.

Earnings Recovery May Rest on Benign Loss Quarters

Based on EG's reported figures, the strongest bull case rests on two quarters with loss ratios below 60%, which may reflect benign catastrophe timing rather than a durable improvement in underwriting.

Q1 2026 posted a 54.5% loss ratio and a 6.12 EPS print in Q3 2026 on a combined ratio of 91.8%, yet the 10-quarter record includes a 110.0% loss ratio only two periods earlier, which argues against extrapolating the recent margin. If softer revenue reflects deliberate underwriting restraint, the margin gain could be temporary if competitors re-enter and rates soften further. Investors should weigh the trailing average combined ratio rather than the best recent quarters before concluding the earnings base has normalized.

EG — Frequently Asked Questions

Quick answers to the most common questions about buying EG stock.

What was Everest Group, Ltd.'s (EG) revenue in 2025?

For fiscal year 2025, Everest Group, Ltd. (EG) reported total revenue of $17.32B. This represents a 1381.1% increase compared to $1.17B in 1996.

Is Everest Group, Ltd. (EG) profitable?

Everest Group, Ltd. (EG) is profitable, generating $1.59B in net income for the fiscal year ending 2025 with a net profit margin of 9.2%.

What is Everest Group, Ltd.'s operating profit margin?

Everest Group, Ltd. (EG) reported an operating income of $1.95B, resulting in an operating profit margin of 11.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Everest Group, Ltd.'s gross profit and gross margin?

Everest Group, Ltd. (EG) generated $3.55B in gross profit for the year, representing a gross profit margin of 20.5%. This demonstrates the company's core pricing power and production efficiency.